Antibiotic use during cytarabine consolidation in acute myeloid leukemia
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-020-04238-5
Abstract: Acute myeloid leukemia (AML) patients undergoing consolidation chemotherapy with intermediate or high-dose cytarabine (IDAC/HiDAC) are often placed on prophylactic antibacterials. This practice is largely based on the benefits of prophylaxis (PPX) during induction chemotherapy. However,… read more here.
Keywords: idac hidac; consolidation; myeloid leukemia; cytarabine ... See more keywords